Dillon & Associates Inc. Cuts Stock Position in Danaher Corporation (NYSE:DHR)

Key Points

• Dillon & Associates Inc. reduced its stake in Danaher Corporation by 2.9% in Q1, now holding 48,099 shares worth approximately $9.86 million.
• Analysts have lowered their price targets for Danaher, with HSBC and Deutsche Bank cutting theirs to $240.00 and $235.00, respectively, while the current consensus rating remains a "Moderate Buy".
• Danaher reported earnings of $1.80 per share for the last quarter, surpassing estimates, with a revenue of $5.94 billion, marking a 3.4% year-over-year increase.

Dillon & Associates Inc. lessened its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 2.9% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 48,099 shares of the conglomerate's stock after selling 1,416 shares during the period. Danaher accounts for approximately 1.5% of Dillon & Associates Inc.'s holdings, making the stock its 21st biggest position. Dillon & Associates Inc.'s holdings in Danaher were worth $9,860,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. Fayez Sarofim & Co lifted its stake in Danaher by 0.6% in the 4th quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate's stock valued at $1,902,000 after buying an additional 50 shares in the last quarter. Coastal Bridge Advisors LLC lifted its stake in Danaher by 4.8% in the 4th quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock valued at $252,000 after buying an additional 50 shares in the last quarter. MGO One Seven LLC lifted its stake in Danaher by 1.3% in the 4th quarter. MGO One Seven LLC now owns 4,285 shares of the conglomerate's stock valued at $984,000 after buying an additional 53 shares in the last quarter. Hills Bank & Trust Co lifted its stake in Danaher by 0.3% in the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock valued at $3,693,000 after buying an additional 53 shares in the last quarter. Finally, Sageworth Trust Co lifted its stake in Danaher by 2.3% in the 1st quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock valued at $493,000 after buying an additional 54 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on DHR shares. HSBC decreased their price target on shares of Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Evercore ISI decreased their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. The Goldman Sachs Group decreased their target price on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Three investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

Danaher Stock Up 1.1%

Danaher stock opened at $200.70 on Monday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The firm has a 50 day moving average price of $198.46 and a 200 day moving average price of $200.62. The company has a market capitalization of $143.71 billion, a PE ratio of 42.70, a price-to-earnings-growth ratio of 2.80 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the firm earned $1.72 EPS. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.